References
- Tiwari RK, Moin A, Rizvi SM, Shahid SM, Bajpai P. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?. Metabolic Brain Disease. 2021 Jun;36(5):829-47.
- Rekatsina M, Paladini A, Piroli A, Zis P, Pergolizzi JV, Varrassi G. Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review. Advances in therapy. 2020 Jan;37:113-39.
- Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nature Neuroscience. 2016 Aug;19(8):987–991. DOI: 10.1038/nn.4338
- Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Science. 2017 Jan 13;356(6339):766–771. DOI: 10.1126/science.aal2001
- Greiner T, Kipp M. What guides peripheral immune cells into the central nervous system?. Cells. 2021 Aug 10;10(8):2041.
- Paolicelli RC, Sierra A, Stevens B, Tremblay MÈ, Aguzzi A. Microglia states and nomenclature: A unified framework. Neuron. 2022 Dec 21;110(24):4036-4053. doi:10.1016/j.neuron.2022.10.020.
- Loera-Valencia R, Cedazo-Minguez A, Kenigsberg PA, Page G, Duarte AI, Giusti P, Zusso M, Robert P, Frisoni GB, Cattaneo A, Zille M. Current and emerging avenues for Alzheimer’s disease drug targets. Journal of internal medicine. 2019 Oct;286(4):398-437.
- Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, Løvik M. Inflammatory disease processes and interactions with nutrition. British Journal of Nutrition. 2009 May;101(S1):1-45.
- EDİCİ PH. NEUROINFLAMMATION MODIFYING APPROACHES IN PARKINSON’S DISEASE.
- Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. Journal of pharmacy & pharmaceutical sciences. 2008 Sep 20;11(2):81s-110s.
- A Frankola K, H Greig N, Luo W, Tweedie D. Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2011 May 1;10(3):391-403.
- Dendrou CA, McVean G, Fugger L. Neuroinflammation—using big data to inform clinical practice. Nature Reviews Neurology. 2016 Dec;12(12):685-98.
- Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM, Teleanu RI. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. International journal of molecular sciences. 2022 May 25;23(11):5938.
- Rajasekhar K, Govindaraju T. Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer’s disease. RSC advances. 2018;8(42):23780-804.
- Luo XG, Chen SD. The changing phenotype of microglia from homeostasis to disease. Translational neurodegeneration. 2012 Dec;1:1-3.
- Zhao N, Francis NL, Calvelli HR, Moghe PV. Microglia-targeting nanotherapeutics for neurodegenerative diseases. APL bioengineering. 2020 Sep 1;4(3).
- Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G. Role of microglia and astrocytes in Alzheimer’s disease: from neuroinflammation to Ca2+ homeostasis dysregulation. Cells. 2022 Sep 1;11(17):2728.
- Thirumalaisamy R, Bhuvaneswari M, Haritha S, Jeevarathna S, Janani KS, Suresh K. Curcumin, naringenin and resveratrol from natural plant products hold promising solutions for modern world diseases–A recent review. South African Journal of Botany. 2022 Dec 1;151:567-80.
- Marcuzzi A, Rimondi E, Melloni E, Gonelli A, Grasso AG, Barbi E, Maximova N. New applications of JAK/STAT inhibitors in pediatrics: current use of ruxolitinib. Pharmaceuticals. 2022 Mar 19;15(3):374.
- Andelova K, Bacova BS, Sykora M, Hlivak P, Barancik M, Tribulova N. Mechanisms underlying antiarrhythmic properties of cardioprotective agents impacting inflammation and oxidative stress. International Journal of Molecular Sciences. 2022 Jan 26;23(3):1416.
- Fu H, Alabdullah M, Großmann J, Spieler F, Abdosh R, Lutz V, Kalies K, Knöpp K, Rieckmann M, Koch S, Noutsias M. The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation. Cell death & disease. 2019 Nov 21;10(12):880.
- Jamshidnejad-Tosaramandani T, Kashanian S, Al-Sabri MH, Kročianová D, Clemensson LE, Gentreau M, Schiöth HB. Statins and cognition: Modifying factors and possible underlying mechanisms. Frontiers in Aging Neuroscience. 2022 Aug 15;14:968039.
- Bagheri H, Ghasemi F, Barreto GE, Sathyapalan T, Jamialahmadi T, Sahebkar A. The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review. Biofactors. 2020 May;46(3):309-25.
- Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z, Aloizou AM, Nikolaidis I, Bakirtzis C, Tsivgoulis G, Deretzi G. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. Autoimmunity Highlights. 2019 Dec;10:1-25.
- Lee Y, Lee S, Chang SC, Lee J. Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention. Archives of pharmacal research. 2019 May 1;42:416-25.
- Perlikowska R. Whether short peptides are good candidates for future neuroprotective therapeutics?. Peptides. 2021 Jun 1;140:170528.
- Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges. Cellular and Molecular Life Sciences. 2022 Apr;79(4):219.
- Vatansever S, Schlessinger A, Wacker D, Kaniskan HÜ, Jin J, Zhou MM, Zhang B. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Medicinal research reviews. 2021 May;41(3):1427-73.
- Chanda S, Ramachandra TV. Phytochemical and pharmacological importance of turmeric (Curcuma longa): A review. Research & Reviews: A Journal of Pharmacology. 2019 Feb;9(1):16-23.
- Punukollu RS, Chadalawada AK, Siddabattuni K, Gogineni NT. A blend of Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit extracts relieves constipation and improves bowel function: A proof-of-concept clinical investigation. Journal of Ethnopharmacology. 2024 Jan 10;318:116997.
- Koníčková D, Menšíková K, Tučková L, Hényková E, Strnad M, Friedecký D, Stejskal D, Matěj R, Kaňovský P. Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status. Biomedicines. 2022 Jul 21;10(7):1760.
- Ahmad A, Imran M, Ahsan H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel Biomarkers of diseases. Pharmaceutics. 2023 May 31;15(6):1630.
- Zeynalzadeh E, Khodadadi E, Khodadadi E, Ahmadian Z, Kazeminava F, Rasoulzadehzali M, Kafil HS. Navigating the neurological frontier: Macromolecular marvels in overcoming blood-brain barrier challenges for advanced drug delivery. Heliyon. 2024 Aug 15;10(15).